Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D03JTL
|
|||
Drug Name |
APVO414
|
|||
Synonyms |
MOR209/ES414
Click to Show/Hide
|
|||
Indication | Prostate cancer [ICD-11: 2C82.0] | Phase 1 | [1] | |
Company |
Aptevo Therapeutics Seattle, WAMorphoSysPlanegg, Germany
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Glutamate carboxypeptidase II (GCPII) | Target Info | Inhibitor | [2] |
KEGG Pathway | Alanine, aspartate and glutamate metabolism | |||
Metabolic pathways | ||||
Vitamin digestion and absorption | ||||
NetPath Pathway | TCR Signaling Pathway | |||
TNFalpha Signaling Pathway | ||||
Reactome | Amino acid synthesis and interconversion (transamination) | |||
WikiPathways | One Carbon Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.